SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-023087
Filing Date
2021-04-27
Accepted
2021-04-27 16:22:43
Documents
5
Period of Report
2021-04-27
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea139985-8k_inmedpharma.htm 8-K 31910
2 NEWS RELEASE, DATED APRIL 26, 2021 ea139985ex99-1_inmedpharma.htm EX-99.1 17262
3 NEWS RELEASE, DATED APRIL 27, 2021 ea139985ex99-2_inmedpharma.htm EX-99.2 13281
4 GRAPHIC ex99-1_001.jpg GRAPHIC 16784
5 GRAPHIC ex99-2_001.jpg GRAPHIC 16784
  Complete submission text file 0001213900-21-023087.txt   110073
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39685 | Film No.: 21859233
SIC: 2834 Pharmaceutical Preparations